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1. Introduction 
Cardiothoracic surgeons are faced with the challenge of protecting the brain during the 
sensitive time of interruption of normal cerebral blood flow.  The brain is an exceptionally 
complex organ with a functional anatomy that is difficult both to understand and assess.  
Experimental and clinical studies have shown that the mechanism of neural injury is 
multifactorial. As such, discussions regarding the best surgical strategies for 
neuroprotection during circulatory arrest are formidable, at best. Although we are armed 
with excellent experimental and clinical studies that demonstrate the deleterious effects of 
prolonged exposure to cardiopulmonary bypass (CPB) on brain function and structure, the 
various neuroprotective strategies, particularly that of deep hypothermic circulatory arrest 
(DHCA) remain an issue of debate. This is related in part to the gap between the basic 
science understanding of brain injury caused by these events and the clinical application of 
various neuroprotective strategies and their subsequent clinical outcomes. The goal here is 
to address the current understanding of the mechanisms underlying brain injury after HCA 
and relevant strategies of neural protection, supported by primary experimental data from 
our laboratory. 
2. Hypothermic ciruclatory arrest 
The use of therapeutic hypothermia dates back to the ancient Egyptians, Greeks, and 
Romans. In modern times, the use of therapeutic hypothermia progressed from observation 
case reports to animal studies to clinical use in children and then adults. Initially there were 
observational reports of therapeutic use of hypothermia in patients with severe cerebral 
trauma, followed by experimental studies in dogs that suggested a therapeutic role for 
hypothermia for cerebral protection during cardiac surgery. Later, profound hypothermia 
(12° C, nasopharyngeal) with circulatory arrest (up to 1 hour) was used in children 
undergoing surgical repair of the tetralogy of Fallot. (Apostolakis & Shuhaiber, 2007) 
The use of deep hypothermic cardiopulmonary arrest (DHCA, 14-18°C) was first applied as 
a method for cerebral protection during the prosthetic replacement of the aortic 
arch.(Griepp et al, 1997) Later, the use of a DHCA was extended into other major vascular 
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surgeries such as the repair of thoracoabdominal aortic lesions, clipping of giant and 
complex cerebral aneurysms, and resection of renal carcinoma with tumor thrombus 
extending into the inferior vena cava or atrium.    
Deep hypothermic circulatory arrest (DHCA or HCA) provides 2 clinical benefits. The 
circulatory arrest component provides a bloodless surgical field without the need for the use 
of intrusive clamps and cannulae. The deep hypothermic component significantly decreases 
brain metabolism and oxygen requirements and thus permits a longer period of interrupted 
blood perfusion to the brain. The cerebral metabolic rate is related exponentially to brain 
(core body) temperature, with the cerebral metabolic rate decreasing by about 50% for each 
6°C drop in brain temperature. Since the first experimental studies, the use of DHCA has 
become the standard technique for the surgical repair of certain congenital and acquired 
cardiovascular lesions. The outcome after these operations improved considerably over the 
past two decades and surgery requiring HCA can usually be performed with an acceptable 
risk for the patient. However, it is likely that these improvements are more a consequence of 
an increasing expertise with this type of surgery, rather than the influence of one particular 
organ protection method employed. Despite this fact, there is still room for improvement, 
since prolonged periods of HCA are still associated with significant morbidity and 
mortality. As the brain is the organ most sensitive to ischemic damage, it is considered to be 
the limiting factor for the duration of HCA. Nevertheless, despite its protective effects, HCA 
can be detrimental for other organ systems. 
The basic established techniques and perfusion strategies during aortic arch replacement 
number three: hypothermic circulatory arrest (HCA), antegrade cerebral perfusion (ACP), 
and retrograde cerebral perfusion (RCP). During the past decade and after several 
experimental studies, RCP lost its previous place in the armamentarium of brain protection, 
giving it up to ACP as a major method of brain perfusion during HCA. HCA should be 
applied at a temperature of ≈20°C with long-lasting cooling and rewarming and should not 
exceed by itself the time of 20–25 min. RCP does not seem to prolong safe brain-ischemia 
time beyond 30 min, but it appears to enhance cerebral hypothermia by its massive 
concentration inside the brain vein sinuses. HCA combined with ACP, however, could 
prolong safe brain-ischemia time up to 80 min. Cold ACP at 10°–13°C should be initially 
applied through the right subclavian or axillary artery and continued bihemispherically 
through the left common carotid artery at first and later the anastomosed graft, with a mean 
perfusion pressure of 40–70 mm Hg. The safety of temporary perfusion is being confirmed 
by the meticulous monitoring of brain perfusion through internal jugular bulb O2 saturation, 
electroencephalogram, and transcranial comparative Doppler velocity of the middle cerebral 
arteries (Kouchoukos et al, 2003). 
3. Methods of end-organ protection during DHCA  
3.1 Hypothermia 
Hypothermia acts by reducing the metabolic rate of the brain and improving the balance 
between energy supply and demand. Hypothermia reduces cerebral blood flow (CBF) in a 
linear manner, but the decrease in cerebral metabolic rate of oxygen (CMRO2) is not exactly 
linear. On average, the reduction in CMRO2 is about 7%/1°C. Between 37°C and 22°C, 
CMRO2 is reduced by about 5%/1°C, and then the reduction accelerates when CMRO2  
reaches 20% at 20°C and 17% at 18°C, at which point about 60% of patients achieve electrical 
silence on electroencephalography (EEG).  
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3.2 Drug interventions 
To increase the tolerance to ischemia, the use of potentially neuroprotective drugs is an 
appealing concept, especially since the circulatory arrest interval is well defined and allows 
a preischemic treatment. Therefore, it is evident that the use of these pharmaceuticals is 
more promising in HCA patients than for the postischemic treatment of patients after 
embolic strokes. Studies in a chronic porcine model showed that nontoxic drugs are 
available that have neuroprotective effects, making them potential candidates for clinical 
use. Additionally, combining drug treatment with selective perfusion techniques, to support 
adequate delivery of the agent into the target organ, seems to be a promising concept. 
Among the various neuroprotective pharmacologic agents are barbiturates, which are 
believed be protective in focal ischemia by reducing CMRO2, CBF, free fatty acids, free 
radical and cerebral edema. Steroids decrease proinflammatory responses, while beta-
blockers decrease the inflammatory response. Mannitol reduces cerebral edema, scavenges 
free radicals and protects the kidneys by lowering renal vascular resistance. Furosemide 
blocks renal reabsorption of sodium, and insulin controls hyperglycemia, which in turn 
prevents intracellular acidosis.  Lidocaine is a selective blocker of Na+ channels in neuronal 
membranes and thus, reduces CMRO2. Dexmedetomidine inhibits ischemia-induce 
norepinephrine release and is protective for both focal and global ischemia. Acadesine 
appears to mitigate the effects of reperfusion injury. 
3.3 Intraoperative neuromonitoring 
Neurophysiological monitoring during thoracic aortic surgery using HCA became 
increasingly popular in the last decade. Besides its value during an ongoing operation, the 
collection of data in combination with outcome analysis might help to improve or change 
surgical strategies. Continuous recording of electroencephalograms (EEGs) as well as SSEPs 
is now routine in most neurosurgical units. The use of neuromonitoring in cardiothoracic 
surgery is in part hampered by the fact that hypothermia has an impact on the sensitivity of 
neurophysiological measures, so they cannot be used during deep hypothermia. On the 
other hand, some surgeons have found this an asset, and use disappearance of the EEG to 
determine the optimal level of hypothermia before they stop the extracorporeal circulation. 
Therefore, the value of the EEG as an isolated method for ascertaining whether cerebral 
protection is adequate is questionable. Furthermore, nonsynaptic metabolic activity may 
persist even when the EEG is isoelectric. On the other hand, the EEG may provide valuable 
information for those groups which are using relative high blood temperatures during SCP. 
Furthermore, EEG seems to be a good tool for detecting electrophysiological recovery in the 
early postoperative period. Monitoring of SSEPs is generally easier than EEG since electric 
noise does not play such a substantial role. It is generally less influenced by anesthetic 
drugs, and it remains detectable as long as cortical activity can be encountered. From clinical 
experience, SSEPs seem especially valuable during surgery on the descending or 
thoracoabdominal aorta (which is not subject of the present synopsis) but muscle evoked 
potentials (MEPs) may be even more sensitive for detection of spinal cord injury. 
3.4 Acid-base management during hypothermia  
Hypothermia alters the results of analysis of arterial blood gases by increasing the solubility 
of CO2 and O2 in plasma. The increase in CO2 solubility decreases the concentration of the 
insoluble portion and, thus, the partial pressure. However, the total content of CO2 in the 
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blood remains the same. During hypothermia, if a blood sample is taken and warmed to 
37°C in the blood gas analyzer, the CO2 initially dissolved will now contribute to the partial 
pressure of CO2 (PCO2) and the PCO2 will be within the normal normothermic range. If, on 
the other hand, the value is estimated at the patient’s actual temperature, the PCO2 will be 
reduced despite similar arterial CO2 content. In addition to its effect on gas solubility, 
hypothermia decreases the metabolic rate and CO2 production. Maintaining the PCO2 within 
the normal range in rewarmed  37°C blood is called “alpha-stat.” If the PCO2 is corrected to 
the patient’s actual temperature and that value is kept within the normal range, the 
management is called “pH-stat.” 
4. Duration of DHCA 
A number of biochemical and cellular structural changes take place as the duration of 
circulatory arrest lengthens. After 15 minutes of ischemia at 18°C, the recovery of oxygen 
consumption is impaired, and after 20 minutes, cerebral lactate is detected in the effluent 
blood. The safe duration of circulatory arrest at 15°C was predicted to be about 29 minutes 
and at 10°C about 40 minutes. If ischemic tolerance is considered 5 minutes at 
normothermia, the calculated safe period of circulatory arrest at 18°C would be 15 minutes. 
Clinical studies have shown a persistent loss of cognitive function (lasting more than 6 
weeks) and deterioration in postoperative cognitive scoring/testing in patients who 
underwent aortic arch surgery by using DHCA for more than 25 minutes at 10°C. 
5. Complications of DHCA 
Disadvantages of DHCA include increased cardiopulmonary bypass (CPB) time, edema 
formation, coagulopathy, and alteration in many organ functions including the kidney, the 
brain, vascular smooth muscles, intestinal mucosa, alveolar epithelium, the liver, and the 
pancreas. Based on reports from 8 major cardiac surgery centers in the United States, 
Europe, and Japan, the risk of permanent neurologic injury after aortic arch surgery using 
DHCA ranged from 3% to 12%, renal dysfunction from 5% to 14%, pulmonary insufficiency 
from 5% to 39%, and left ventricular failure or low-cardiac-output syndrome from 7% to 
34%. Alternatives to the use of DHCA during aortic arch replacement are the use of 
normothermic CPB or mild-to-moderate degrees of hypothermia. These alternatives 
obviously require  the use of a perfusion system for the brain, separate from the rest of the 
body, which might increase the risk of cerebral emobilization.   
5.1 Neurologic injury  
Neurologic injury is the most troublesome adverse effect of DHCA and CPB, presenting 
either as transient neurologic deficit (5.9%-28.1%) or irreversible neurologic injury (1.8%- 
13.6%). Early postoperative mortality markedly is increased (18.2%) in patients with 
neurologic injury, and long-term cognitive disability is common among survivors.  
Neurologic deficit after DHCA encompasses a wide scale of disorders ranging from deep 
coma to subtle, hardly perceptible alterations in cognitive functions or behavior. In the 
immediate postoperative period, the return of sophisticated neurologic functions is often 
obscured by the administration of sedative and analgesic agents. Neurologic injury presents 
at that time mostly as a focal or diffuse deficit. A focal deficit is due to interruption of blood 
in a terminal vascular territory, usually following embolism of material or gas bubbles. The 
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clinical expression is typically motor-sensory deficit, aphasia, or cortical blindness (Kunihara 
et al, 2005; Lipton, 1999). Computed tomography and magnetic resonance imaging are 
usually able to detect a sharply demarcated area of necrosis in the brain. 
A focal deficit is usually an embolic phenomenon, whereas a prolonged poor perfusion of 
the brain may produce necrosis in watershed zones. Age, atherosclerosis, and manipulation 
of the aorta are risk factors for both. Global cerebral ischemia leads to diffuse neurologic 
deficit, which may be benign and reversible or more debilitating (seizures, Parkinsonism, 
and coma). Risk factors include increased duration of circulatory arrest and CPB, diabetes 
mellitus, and hypertension. Transient neurologic dysfunction appears to be a marker of 
long-term cerebral injury. Deficits of memory and fine-motor function may persist after 
hospital discharge. Reductions in CMRO2 and the duration of DHCA reduce the risk of 
neurologic injury. The length of time on CPB might be a better predictor of postoperative 
death and stroke than the duration of DHCA time (Hagl et al, 2003). 
Aortic procedures requiring hypothermic circulatory arrest have been specifically correlated 
with increased risk of both stroke and mortality in all patients. This may be accentuated in 
the elderly, who may have less tolerance for neurological insult.  Many physicians think 
patients >75 years old are too frail and lack the reserve to survive a major cardiothoracic 
surgery. In particular, there remains some hesitancy in performing procedures with a higher 
risk of stroke in patients with a higher susceptibility for adverse neurological sequelae. This 
perceived combination of risk and susceptibility may be a barrier to care for elderly patients 
requiring hypothermic circulatory arrest to address their aortic pathology. According to 
Coselli et al. (2008), in a study accessing the safety and efficacy of HCA, there are various 
major complications associated with HCA. These included death (interoperative, during 
hospital stay, and within 30 days), stroke, paraplegia, paraparesis, uncontrolled bleeding 
which required reoperation, renal failure, cardiac complications, and vocal cord paralysis. 
6. Strategies for brain protection during DHCA 
6.1 Hypothermia – reduction of metabolism 
Hypothermia is the most efficient measure to prevent or reduce ischemic damage to the 
central nervous system when blood circulation is reduced. The central nervous system has a 
high metabolic rate and limited energy stores, which make it extremely vulnerable to 
ischemia (Elrich et al, 2002).  Hypothermia acts by reducing the metabolic rate of the brain 
and improving the balance between energy supply and demand, and thus lengthens the 
period of tolerated ischemia. Hypothermia reduces cerebral blood flow (CBF) in a linear 
manner, but the decrease in cerebral metabolic rate of oxygen (CMRO2) is not exactly linear. 
On average, the reduction in CMRO2 is about 7%/1°C. Between 37°C and 22°C, CMRO2 is 
reduced by about 5%/1°C, and then the reduction accelerates when CMRO2  reaches 20% at 
20°C and 17% at 18°C, at which point about 60% of patients achieve electrical silence on 
electroencephalography (EEG) (McCullough et al, 1999). 
6.2 Techniques and perfusion strategies 
Although reduction of cerebral metabolism and swift surgery are the two fundamental 
measures that can prevent or reduce brain damage during circulatory arrest, there are 
adjunctive protective measures that can be considered. The basic established techniques and 
perfusion strategies during aortic arch replacement number three: hypothermic circulatory 
arrest (HCA), antegrade cerebral perfusion (ACP), and retrograde cerebral perfusion (RCP). 
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7. Experimental investigation of cerebral injury following DHCA 
A clearer understanding of the consequences of HCA will be pivotal in clinical decision-
making, including when to initiate circulatory arrest and the appropriate interval. Delayed 
cell death is of special interest because of the potential for intervention. Although apoptosis 
is believed to play a part in the cerebral injury, its role has generally been identified through 
histologic techniques. These snapshots do not permit a clear delineation of the time-line of 
apoptosis. Because its role is not clear, therapies have yet to be designed for the specific 
purpose of inhibiting apoptosis.  
The balance between cell survival and death is under tight genetic control (Almeida et al., 
2000). A multiplicity of extracellular signals and intracellular mediators are involved in 
maintaining this balance. When the cell is exposed to physical, biochemical or biological 
injury, or deprived of necessary substances, it activates a series of stress-response genes.  
Although with minimal insults, the cell may recover, with greater insults, single cell death 
results.  The current understanding of the neurons response to insult has been supported by 
evidence from a series of studies using a porcine model system to investigate the effects 
hypothermic circulatory arrest and ischemic insult on the integrity of neuronal populations. 
7.1 Clinically relevant animal models 
Evaluating various strategies and treatments in animal studies in order to determine clinical 
feasibility remains a challenge. Animal models have contributed immensely to our 
understanding of cerebral consequences of HCA, with several animal models having been 
used. To date, the preclinical investigation of cerebral injury mechanisms related to deep 
hypothermic circulatory arrest has been limited to large-animal models (porcine, canine and 
ovine). These models are expensive, personnel demanding, cumbersome and are usually 
performed without validated neuropsychologic assessment. Rodent models have been 
attempted to overcome some of these disadvantages, although treatment effects cannot 
always be confirmed in the rat model. Ultimately, however, each experimental model 
system from cell cultures to rats, to large animals and ultimately to clinical trials, have their 
advantages and disadvantages, and ultimately their place in these investigations.  
Most animal models require an extended period of arrest to produce a reproducible level of 
neuronal injury that would facilitate elucidating the mechanisms of injury and efficacy of 
neuroprotective interventions. Many large animal models require DHCA for at least 90-120 
minutes to demonstrate neurologic deficits. Although such prolonged DHCA interval might 
not be considered clinically realistic, they may be more appropriate for demonstrating the 
molecular pathways behind acute neuronal injury and hence, modes of intervention (Conti 
et al, 1998). 
Study of a neuroprotective strategy includes appropriate selection of an animal model and 
functional indices. The model is selected with respect to their relevance and feasibility of 
assessing the parameters of interest. Investigations of promising neuroprotectvie methods 
require validation (validation study), use in experimental settings to optimize cerebral 
protection during CPB and DHCA (performance study) and test during routine cardiac 
surgery (clinical study). 
Hypothermia is essential for cerebral protection during HCA. Hypothermia reduces 
cerebral metabolic activity, oxygen demand, and prevents the release of neurotransmitters 
and delays the onset of fatal biochemical cascade (Elrich et al., 2002; McCullough et al., 
1999). Although reduced, brain metabolism is not suppressed adequately and remains 
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relatively high at 18°C in traditional HCA protocols (McCullough et al., 1999).   In light of 
evidence suggesting that the apoptotic pathway may be reversible in their earlier stages 
(McCullough et al., 1999), studies from our team were undertaken to assess whether 
cooling to 10°C can reduce neurological injury during 75 minutes of HCA in an acute 
porcine model compared to less profoundly cooled (18°C) animals, as assessed by DNA 
fragmentation, anti-apoptotic protein Bcl-2 expression, and ultrastructural changes in the 
sensory cortex. Sixteen male juvenile pigs from a commercial farm, 2-3 months of age and 
weighing 25-35 Kg were used for this study. The animals were divided into three groups: 
Group A (n=6) underwent hypothermic circulatory arrest at 18oC for 75 min, Group B 
(n=6) underwent hypothermic circulatory arrest at 10oC for 75 min and Group C (n=4) 
served as normal controls. 
Preparation and surgery were performed as previously described (Ananiadou et al 2005). 
Briefly, catheters were inserted in an ear vein and the left femoral artery for monitoring 
purposes and withdrawal of blood samples. Anesthesia was induced with intramuscularly 
ketamine hydrochloride (15 mg/kg), atropine (0.05 mg/kg), and dormicum (0.1 mg/kg) and 
was maintained with intravenous fentanyl (50-200 μg/kg), dormicum and 1% to 2% 
isoflurane. Paralysis was achieved with a bolus intravenous rocuronium (0.6 mg/kg) and 
was maintained with 20% of the total dose every 30 min.  
Animals were ventilated mechanically with 100% oxygen, after endotracheal intubation. 
Ventilator rate and tidal volume were adjusted to maintain the arterial carbon dioxide 
tension at 40 mmHg. Hematocrit values during cardiopulmonary bypass (CPB) were 
maintained between 13%-23%.  A temperature probe was placed in the rectum, while brain 
temperature was determined with bilateral tympanic membrane probes. Urine output was 
collected through a bladder catheter (Foley 8-10 F). Arterial pressure, end-expired carbon 
dioxide, electrocardiogram, and blood gases (ABL Radiometer Medical A/S DK-2700, 
Copenhagen, Denmark) were monitored. 
As previously described, the chest was opened via a right thoracotomy in the fourth 
intercostal space (Ananiadou et al., 2005). After administration of intravenous heparin (300 
IU/kg), cannulas were advanced to the ascending aorta (16 F arterial cannula) and to the 
right atrium (single 26 F cannula). Non-pulsatile CPB, was initiated at a flow rate of 100 
ml/kg per min and then adjusted to maintain a minimum arterial pressure of 50 mmHg. To 
avoid distension of the left ventricle during CPB, a 10 F vent catheter was inserted via the 
superior pulmonary vein. The lungs were allowed to collapse after CPB was initiated. The 
CPB circuit was primed with a bloodless solution consisting of 1000cc lactated Ringer’s, 50 
ml mannitol, and 5000 IU heparin. Sodium bicarbonate was added to adjust the pH to 7.4, as 
necessary.  
CPB was continued for an average 58 or 106 minutes, to reach a deep brain temperature of 
18oC or 10oC, respectively. Myocardial protection was afforded by applying iced saline (4oC) 
topically during the 75-minute interval of hypothermic circulatory arrest. When the 
tympanic membrane temperature reached 18oC or 10oC, bypass was discontinued, the blood 
was drained into the oxygenator reservoir, and circulatory arrest was maintained for 75 
minutes. Ice bags were positioned around the head to maintain the brain temperature 
during HCA. At the end of the arrest, bypass was initiated again with gradual rewarming to 
a rectal temperature of approximately 35oC to 36oC. A temperature gradient exceeding 10oC 
between the perfusate and the core temperature was avoided. A temperature of 36oC was 
reached after an average of 83 or 104 minutes of reperfusion for animals treated with 18 oC 
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or 10 oC HCA, respectively. Systemic pressure was maintained above 60 mmHg during 
reperfusion. Measurements of hemodynamics (heart rate, mean arterial pressure), arterial 
blood gases, hematocrit, glucose lactate, as well as temperatures were recorded at five time 
points during the experiment. These were: 1) Baseline at 37oC and prior to CPB; 2) At the 
initiation of CPB; 3) During CPB, while cooling to a brain temperature of 18oC or 10oC just 
before HCA; 4) During rewarming; and 5) At the end of CPB. 
The mean duration (+SD) of CPB cooling and CPB warming for animals with 18oC HCA was 
57.50+17.25 and 82.50+10.37 minutes, and for 10oC was 105.8±21.8 and 104.2±19.8 minutes, 
respectively.  Perioperative physiological variables are shown in Table 1. Although there 
were some minor variations, no apparent clinically relevant hemodynamic differences were 
observed between treatment groups. Lactate levels were significantly higher following HCA 
at 10oC compared to 18oC. PO2 levels were significantly lower in 18oC HCA animals 
compared to 10oC during cooling, and hematocrit levels dropped to a similar degree in all 
experimental animals during the procedure. 
 
Variable Baseline Init CPB Cooling Warming End CPB  
 
Brain Temperature (oC) 
18 oC 36.5+0.4 34.1+1.8 18.0+0.0 25.8+3.2 36.5+0.8 
10 oC 36.5+0.4 33.2+1.6 10.0+0.0 28.2+3.1 36.9+0.2 
 
MAP (mmHg) 
18 oC 114.0+14.9 57.2+16.3 55.2+8.1 67.8+15.7 68.3+25.7 
10 oC 118.7+13.0 59.7+10.1 54.0+3.4 69.4+16.5 85.0+8.9 
 
Arterial pH  
18 oC 7.40+0.12 7.26+0.19 7.26+0.12 7.20+0.07 7.35+0.14 
10 oC 7.34+0.13 7.32+0.11 7.28+0.11 7.32+0.08 7.38+0.13 
 
pO2 (mmHg) 
18 oC 409.9+67.8 751.4+202.8 787.1+319.06* 429.0+126.9 424.6+112.1 
10 oC 378.4+118.3 689.5+45.5 1066.0+122.8 562.8+123.4 459.4+45.4 
 
pCO2 (mmHg) 
18 oC 51.32+19.0 73.7+37.8 67.2+31.3 69.3+14.4 38.7+18.7 
10 oC 58.1+23.3 60.0+17.7 58.2+12.4 44.0+12.9 31.7+9.0 
 
Hematocrit (%) 
18 oC 26.4+3.8** 16.4+3.4 15.51+3.3 16.6+3.9 15.5+3.1 
10 oC 26.0+3.8** 18.5+3.0 18.6+3.7 19.2+3.5 19.2+3.0 
 
Lactate (mmol/L) 
18 oC 2.7+1.8 4.5+2.1 5.6+2.5 6.3+1.7* 11.0+4.3 
10 oC 3.1+1.03 4.4+1.6 8.3+3.0 11.6+2.8 11.9+3.5 
 
 
Table 1. Typical Physiologic Variables During HCA Paradigm in a Porcine Model 
All values are expressed as mean + SD. *P<0.05 between animals treated with HCA at 18oC 
vs 10oC (unpaired, 2-tailed, t-test). **P<0.05 between sample times (ANOVA followed by 
Fisher PLSD).   
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8. Neuronal injury and nerve cell death: basic sciences 
Neuronal death is normal during development of the nervous system, but it is abnormal 
in brain and spinal cord disease and injury. The available evidence indicates that the 
survival of neurons and their death are highly regulated and finely orchestrated dynamic 
events that depend on a number of internal and external factors. Two types of cell death 
are recognized: cell necrosis resulting from injury and causes inflammation and apoptosis, 
observed normally in development and now identified as programmed cell death. 
Apoptosis and necrosis are types of cell death. They are generally considered to be 
distinct forms of cell death, but there is mounting evidence supporting an apoptosis-
necrosis cell death continuum (Portera-Calliau, et al, 1997). In this continuum, neuronal 
death can result from varying contributions of coexisting apoptotic and necrotic 
mechanisms, resulting in some of the distinctions between apoptosis and necrosis 
becoming blurred. Today it is believed that apoptosis may contribute to the neuronal 
degeneration in neurological injuries such as cerebral ischemia and trauma (Kerr et al 
1972; MacManus and Linnik, 1997; Martin, 2001). 
Necrosis can result from acute oxidative stress characterized by passive cell swelling, rapid 
energy losss, and generalized disruption of internal homeostasis with lysis of the nucleus, 
intra-nuclear organelles and plasma membranes leading to the release of intracellular 
components that induce a local inflammatory response that in turn, result in edema and 
injury to neighboring cells. Morphologically, cell death is characterized by swelling of 
organelles and rupture. Necrotic cell death is characterized by inflammation and wide-
spread damage. 
Apoptosis is a process of cell suicide, the mechanisms of which are encoded in the 
chromosomes of all nucleated cells.  Although the capacity to carry out apoptosis appears to 
be inherent in all cells, the susceptibility to apoptosis varies markedly and is influenced by 
external and cell-autonomous events. Apoptosis is regulated by complex molecular 
signaling systems resulting in an orderly, energy-dependent enzymatic breakdown into 
characteristic molecular fragments, DNA, lipids and other macromolecules.  Apoptosis can 
be induced by cell surface receptor engagement, growth factor withdrawal and DNA 
damage. In contrast to those observed in cell necrosis, the morphological changes that occur 
during developmental cell death include cell shrinkage, membrane blebbing, chromatin 
condensation and DNA fragmentation. Earlier studies showed that one of the biochemical 
hallmarks of apoptosis is DNA cleavage at internucleosomal linker regions, resulting in 
ladder formation of DNA of 180-200 bp or multiples thereof. However, this ladder-type 
DNA fragmentation is also found in some cells dying of necrosis, indicating that DNA 
fragmentation cannot be the sole criterion, but simultaneous morphological assessment 
must also be done for identifying apoptosis. 
8.1 Mechanisms of apoptotic cell death 
Several families of proteins and specific biochemical signal-transduction pathways regulate 
cell death. Cell death signaling can involve plasma membrane death receptors, 
mitochondrial death proteins, proteases, kinases and transcription factors. Predominant 
factors in cell death and cell survival include fas receptor, Bcl-2 and Bax (and their 
homologues), cytochrome c, caspases, p53 and extra cellular signal-regulated protein 
kinases. Some forms of cell death require gene activation, RNA synthesis and protein 
synthesis, whereas other forms are transcriptionally-translationally independent and are 
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driven by posttranslational mechanisms such as protein phosphorylation and protein 
translocation. 
The precise signaling cascade starting from the detection of the signal at the cell surface to 
the events that occur in the nucleus in apoptosis is not well established, with several grey 
zones in most suggested pathways.  However, many events that occur at the cell surface and 
intracellularly during apoptosis in the nervous system have been reported. Following an 
appropriate stimulus, the first stage or “decision phase” of apoptosis is the genetic control 
point of cell death. This is followed by the second state or “execution phase”, which is 
responsible for the morphological changes of apoptosis. The decision phase or genetic 
control appears to be mediated by two genes Bcl-2 and p53, while the execution phase 
appears to result from the activation of caspases. It has become apparent that the Bcl-2 
family of proteins constitutes a critical intracellular checkpoint within a distal common 
pathway of programmed cell death (Almeida et al, 2000).  
8.2 Selective vulnerability of neural populations to neural insult after HCA 
After assessing acute neuronal injury in various regions of the brain after HCA in a porcine 
animal model, we found that neurons in the sensory and motor neocortex, as well as those 
in the hippocampus, were vulnerable to cell injury acutely after 75 min of HCA at 18oC, as 
determined by a positive TUNEL reaction for DNA fragmentation (Ananiadou et al, 2005).   
TUNEL positive cells are identified by a red-stained, condensed nucleus with apoptotic 
bodies, along with a diminutive or absent cytoplasm. (Figure 1) Although nerve cell 
populations in the cerebellum, thalamus and ventral medulla were also found vulnerable to 
cell injury, the percentage of TUNEL positive cells in these areas was significantly less than 
that observed in the primary motor and sensory gray matter, and in the hippocampus. 
(Table 2) 
 
 
Fig. 1. Typical Presentation of TUNEL Positive Cells.   
Photomicrograph showing apoptosis in the brain following HCA in an acute porcine model.  
Cluster of TUNEL (+) apoptotic neurons (nucleus is red stained) are interspersed among 
normal neurons in the anteroventral medulla. (magnification x400) 
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Brain Region 18
o
C 10
o
C Control 
Motor Cortex 3.28+0.32* 1.79+0.38+ 0.50+0.22 
Sensory Cortex 3.88+0.13** 1.60+0.31+++ 0.14+0.14 
Hippocampus 2.67+0.36* 1.39+0.24++ 0.17+0.17 
Cerebellum 2.13+0.48 1.82+0.23++ 0.71+0.18 
Medulla 2.00+0.41 2.08+0.23+++ 0.57+0.20 
Thalamus 2.33+0.67 1.54+0.31+++ 0.00+0.00 
  
Table 2. TUNEL Scores in Brain Regions of Animals Treated with HCA   
All values are expressed as mean + SE. *p<0.006 and **p<0.0001 compared to values from 
animals treated with 10oC HCA.  +p<0.05; ++p<0.005; +++p<0.002 compared to normal 
control levels. 
Age and temperature appear to influence neuronal injury, by making certain nerve cell 
populations more vulnerable to injury. In particular, the hippocampus, cerebellum, 
striatum, thalamus, amygdala and neocortex have been reported vulnerable in adult 
normothermic ischemia. In contrast, newborns were more vulnerable to injury in the 
neocortex and striatum. In the present model of hypothermic ischemia in juvenile pigs, the 
neocortex and hippocampus demonstrated the greatest vulnerability to insult during HCA. 
The apparent higher level of TUNEL positive cells in the primary sensory cortex (post-
central gyrus) is not clear. 
Although these previous studies clearly support that some of the cell death observed in 
HCA is via an apoptotic pathway, the experimental conditions used may underestimate the 
contribution of apoptosis to the cerebral sequelae after HCA (Kurth et al, 1999; Hagl et al, 
2001). In this regard, some authors have expressed concern regarding the temporal pattern 
of brain damage and apoptosis after HCA. Thus, although recently improved methods of 
perfusion-fixation and more sophisticated analysis, have clearly shown the HCA initiates a 
series of events that ultimately leads to cell death via a typical apoptotic pattern, the time 
course of these events remains unclear. Most of these previous studies use the classic 90-min 
HCA, 20 oC model, which results in more severe cerebral injury than that usually observed 
clinically, where HCA is carried out for shorter intervals. The results from earlier studies 
also demonstrated that serious cell injury exists as early as 6 h after HCA, and that this 
process continues for at least 72h. 
The importance of understanding the time course of events is underscored by an earlier 
study of long-term survivors of the 90-min, 20 oC protocol. Although treatment with CsA 
was reported to improve behavioral recovery after 7 days, at the 7 days time point after 
HCA there was no difference between CsA treated animals and controls for apoptosis 
measures. The authors concluded that they had missed the peak of apoptosis, and that an 
effective reduction in nerve cell injury would be found most likely with CsA treatment had 
they examined brain tissues at an earlier time point. 
We found no morphological evidence of apoptosis or necrosis, but significantly greater levels 
of TUNEL positive cells in the brain regions assessed, compared to normal control animals. 
We hypothesize, that these findings indicate an early point of activation of the apoptotic 
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pathway. This is consistent with the rapid cell death observed in normal cell suicide programs 
that can kill a cell within 2 to 3 h. At an earlier time point, such as that in this study, we would 
not anticipate completion of the apoptotic mechanism, resulting in cell death with its classic 
morphological characteristics, but rather the initiation of the cellular response cascade.   
Certain cell populations appeart to be more vulnerable to injury.  In particular, the 
hippocampus, cerebelleum, striatum, thalamus, amygdala and neocortex are more 
vulnerable in adult normothermic ischemia. In contrast, newborns are more vulnerable to 
injury in the neocortex and striatum. Our studies show that hypothermia does not provide 
equal protection to all regions of the brain.  In the juvenile pig model, the neocortex and 
hippocampus demonstrated the greatest vulnerability to insult during HCA. The apparent 
higher level of TUNEL positive cells in the primary sensory cortex (post-central gyrus) is not 
clear, and demands further investigation.  (Figure 2) 
 
 
Fig. 2. Positive TUNEL Reaction in Vulnerable Neural Regions 
Regional pattern of neuronal death after deep hypothermic circulatory arrest in juvenile 
pigs. Each point represents the mean score from six experimental animals for each brain 
region.  The brackets indicate the S.D. Among the HCA treated animals, significantly higher 
concentrations of TUNEL (+) cells were observed in the sensory cortex, motor cortex and 
hippocampus, compared to the cerebellum, thalamus and medulla (P< 0.05 by ANOVA 
followed by Fisher PSLD). Although not statistically significantly greater than the motor 
neocortex and hippocampus, the postcentral gyrus had greater TUNEL scores compared to 
the medulla and thalamus (P<0.01). [*P<0.05 vs sensory and motor cortex, and 
hippocampus; ** P<0.001 vs sensory cortex} 
8.3 Profound hpothermia rduces aoptotic nurologic ijury ater HCA 
The use of HCA in aortic repair and congenital heart surgery is based on the idea of 
reducing the metabolic rate and thus, allowing a more prolonged interval without perfusion 
that can be safely tolerated by the brain. The brain, in general, is very sensitive to hypoxia-
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ischemia because it has a high metabolic rate and small reserve of high-energy 
carbohydrates and phosphates. Several studies have indicated that cerebral metabolism is 
reduced effectively at profound levels of hypothermia, suggesting that protection of the 
brain should be greater when HCA is performed at even lower temperatures, such as that 
used in our studies (Strauch et al, 2005).  
We have found that profound hypothermia at 10°C during HCA resulted in a significant 
reduction in neurological injury in selectively vulnerable brain regions. TUNEL (+) staining 
was significantly less at 10°C in the motor and sensory cortex and the hippocampus 
compared to 18°C HCA, indicating that there was increased cerebral protection (Ananiadou 
et al, 2008). These findings are compatible with previous reports that profound hypothermia 
results in a superior neurological outcome compared to conventional HCA methods. 
Although this study does not elucidate the mechanisms, it does affirm that profound 
hypothermia exerts a neuroprotective effect. 
8.4 The decision phase for apoptotic nerve cell death: evidence for Bcl-2 
Apoptosis is controlled genetically, and two genes, Bcl-2 and p53 are now believed to be 
important.  It is now established that proteins encoded by the Bcl-2 gene family are major 
regulatory components of the apoptotic pathway (Kroemer, 1997). Within the apoptotic 
cascade, several proteins that facilitate neuronal survival compete with molecules that 
contribute to cell death. Ultimately, the final balance between cell survival–promoting 
proteins versus cell death–promoting proteins determines the fate of the cell.  The Bcl-2 
family of proteins plays an important role in this cell survival-cell death decision. 
This hypothesis is supported by our findings in Bcl-2 expression. The Bcl-2 family of 
proteins is important for the regulation of apoptosis during the “decision phase.” An 
increase of Bcl-2 has been suggested as an internal protective mechanism against apoptotic 
cell death, where Bcl-2 is persistently expressed in neurons that survive in ischemia. In the 
present study, brain regions that were selectively vulnerable to neurologic injury, 
particularly the neocortex and hippocampus, showed higher levels of Bcl-2 expression after 
HCA at 18°C compared with other brain regions (thalamus, cerebellum, and medulla). 
Moreover, profound hypothermia at 10°C resulted in a significant decrease in TUNEL 
staining in these brain regions. Although a concomitant increase in Bcl-2 expression was 
observed in the neocortex, it remains unclear whether profound hypothermia deters from 
neuronal injury by activation of anti-apoptotic protein Bcl-2 expression (Ananiadou et al, 
2007). (Table 3) 
 
 
Sensory Cortex 18oC 10oC Control 
 
TUNEL 3.88+0.13** 1.60+0.31*** 0.14+0.14 
Bcl-2 0.83 + 0.31 1.8 + 0.31* 1.8 + 0.63 
  
Table 3. TUNEL Scores and Bcl-2 Immunoreactivity in the Sensory Neocortex of Animals 
Treated with HCA at 18oC or 10oC Compared to Controls 
All values are expressed as mean + SE. 
*p<0.05 compared to values from animals treated with 18oC HCA. 
**p<0.0001 compared to values from animals treated with 10oC HCA.  
***p<0.002 compared to normal control levels 
www.intechopen.com
 
Front Lines of Thoracic Surgery 
 
256 
8.5 Morphological and ultrastructural evidence of neural protectin during profound 
cooling 
Necrosis can be characterized by passive cell swelling, rapid energy losss, and generalized 
disruption of internal homeostasis with lysis of the nucleus, intranuclear organelles and 
plasma membranes leading to the release of intracellualar components that induce a local 
inflammatory response that in turn, result in edema and injury to neighboring cells. 
Morphologically, cell death is characterized by swelling of organelles and rupture. Necrotic 
cell death is characterised by inflammation and wide-spread damage. In contrast to those 
observed in cell necrosis, the morphological changes that occur during apoptotic cell death 
include cell shrinkage, membrane blebbing, chromatin condensation and DNA 
fragmentaion (Kerr et al., 1972). In continuation of the above studies, we assessed the 
morphological evidence that profound cooling of the cortex to 10°C can reduce neurological 
injury during hypothermic circulatory arrest (HCA) in our porcine model. Electron 
microscopy assessed ultrastructural changes indicative of activation of programmed cell 
death.  
Parafin embedded samples described above were dewaxed in xylene. After rehydration 
using graded ethanol, slices were washed in cold 0.1 M sodium cacodylate buffer and fixed 
in 2.5% glutaraldeyde in 0.1 M cacodylate buffer overnight. Samples were washed in cold 
cacodylate buffer and then post-fixed with 1% osmium tetroxide in the same buffer for 1 hr 
at room temperature. After osmium tetroxide treatment, the samples were washed with 0.1 
M sodium cacodylate buffer. The selected area was identified with a dissecting microscope, 
and 2x2x2 mm sections were cut out from the coronal slices and dehydrated in a graded 
series of ethanol, before being embedded in epoxy resin. Blocks were trimmed, and semithin 
0.5-μm sections were cut with an ultramicrotome and stained with toluidine blue for light 
microscopy analysis. Ultrathin (75-90 mm) sections were cut and placed on 200-mesh copper 
grids for double-staining with uranyl acetate and lead citrate. Samples were examined with 
a JEOL JEM 100 CX-II electron microscope. 
Samples were examined in a blind fashion by one observer using a JEOL 100CX electron 
microscope who was instructed to find 10 representative neurons (per experimental brain 
specimen) as identified by a typical nucleus and surrounding perikaryon. Two blinded 
investigators using an objective grading system analyzed electron micrographs of these 
neurons. Each investigator was asked to examine each neuron for evidence of nuclear 
changes (chromatin dispersion or clumping), for the presence of cytoplasmic changes, for 
the overall shape of the neuron (shrunken, swollen) and the appearance of rough 
endoplasmic reticulum (RER) compared with matched controls. Similarly, each investigator 
was instructed to examine the perinuclear neuronal mitochondria for abnormalities in 
mitochondrial distribution or shape, matrix density, crystal structure, and appearance of 
any abnormal structures compared with matched controls; each finding was indicated as 
mild, moderate, or severe depending on its frequency.  
Electron microscopic observations in our study provided no appreciable morphological 
evidence to confirm apoptosis or necrosis of the sensory cortical neurons in this acute 
paradigm of HCA. In general, neurons showed normal nuclear and cytoplasmic 
morphology in all three treatment groups, with only minor ultrastructural changes observed 
ater HCA at 18°C. There was no evidence of cells swelling.  The neurons of the sensory 
cortex in control animals had large round or oval nuclei with an evenly distributed 
chromatin. No discontinuities were found in cytoplasmic membrane and nucleolemma. 
Well-developed rough endoplasmic reticulum (RER) that was arranged in parallel stacks 
was observed in the cytoplasm. Polyribosomes formed characteristic rosettes, and 
mitochondria appeared normal in all control animals. Blood capillaries were surrounded by 
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thin astrocytic end feet and showed endothelial cells with euchromatic nuclei, tight 
junctions between the adjacent plasma membranes. 
Compared to normal controls, treatment with HCA at 18°C (group A) resulted in minor 
ultrastructural alterations in the sensory cortex. (Table 4) Most neurons exhibited a pale round 
or oval nuclei. Nucleoli were intact, although sometimes they were localized in eccentric 
positions. Plasma and nuclear membranes remained intact, as did the mitochondria, which 
maintained their normal appearance, with recognizable cristae. While most neurons had 
slightly dilated RER and Golgi apparatus, some cells displayed more significant edema and 
morphological modifications of their organelles and dilated mitochondria. (Figure 3). In some 
cases, polysomes were disassociated, displaying desegregated ribosomes. In addition, some 
neurons, also exhibited some chromatin clumps.  Although some mitochondria were slightly 
dilated, they showed an otherwise normal morphology.  
 
    
Fig. 3. Ultrastructural Changes in the Sensory Cortex 
Sensory cortex from HCA at 18oC. (Left) Electron micrograph following HCA at 18oC with 
detail of neuron, showing nucleus(x18400). (Right) The same neuron showed dilated rough 
endoplasmic reticulum (x25200). 
 
 Sensory cortex 
 
 
Treatment 
Overall shape of the 
neuron 
Nuclear changes Cell organelles 
Shrunken 
 
10oC 18oC 
Swollen 
 
10oC 18oC
Chromatin 
Dispersion 
10oC    18oC
Clumping 
 
10oC    18oC
Mitochondri
al Swelling 
10oC    18oC
RER 
Swelling 
10oC    18oC 
       
1 -         - -        - -         - -         - -         + -        + 
2 -         - -        - -         - -         - -         - -        - 
3 -         - -        - -         - -         - -         + -        + 
4 -         - -        - -         - -         - -         + -        + 
Table 4. Ultrastructural Changes in the Sensory Neocortex of Animals Treated with HCA at 
18oC or 10oC Compared to Controls 
-  No changes noted compared to control 
+ Positive observation compare to control animals  
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Deep hypothermia at 10°C resulted in negligent ultrastructural changes in the sensory 
cortex. Most neurons exhibited pale round or oval nuclei and intact nucleoli. In a few cases, 
the nucleoli were localized in eccentric positions. Plasma and nuclear membranes remained 
intact, and the structure of the cytoplasmic organelles was similar to that observed in control 
animals.  
The first stage or the decision phase of apoptosis is initiated after an appropriate stimulus. 
This is referred to as the genetic control point of cell death and appears to be regulated by 
the Bcl-2 family of genes. The “execution phase” which follows is responsible for the 
morphologic changes of apoptosis (Kam and Ferch, 2000). The absence of clear morphologic 
evidence of apoptosis potentially suggests that these observations may represent an early 
point of activation of the apoptotic pathway (decision phase), which is supported by the Bcl-
2 expression findings.  As important regulators of the “decision phase,” an increase of Bcl-2 
may represent an internal protective mechanism against apoptotic cell death. Bcl-2 is 
persistently expressed in neurons that survive in ischemia. The sensory cortex is selectively 
vulnerable to neurologic injury and showed high levels of Bcl-2 expression after HCA at 
18°C compared (Ananiadou et al., 2008). Moreover, profound hypothermia at 10°C resulted 
in a significant decrease in TUNEL(+) staining in this brain region. The concomitant increase 
in Bcl-2 expression that was observed in the sensory neocortex, suggests that profound 
hypothermia (at 10°C) may deter from neuronal injury by activation of anti-apoptotic 
protein Bcl-2 expression (Almeida et al., 2000).  Although subtle, electron microscopy 
showed that at 18°C cells exhibited dilation of the rough endoplasmic reticulum and 
mitochondria, ribosome detachment and Golgi derived vacuolation, while at 10°C cells 
exhibited only dilation of the rough endoplasmic reticulum and ribosome detachment, 
indicating Phase II and Phase I of the apoptotic process, respectively. 
The observation that TUNEL labeled cells may eventually, but not necessarily, progress into 
morphologically distinct apoptotic cells also confirms the idea that different morphologic 
characteristics may reflect different stages of the same death process.  This is supported by 
our electron microscopy findings.  At 18°C HCA, the neurons of the sensory cortex 
displayed dilation of the rough endoplasmic reticulum and detachment of ribosomes, along 
with Golgi derived vacuolation.  According to Portera-Cailliau and colleagues (Portera-
Calliau, et al., 1997), these findings suggest that the sensory cortex was in Phase II of the 
apoptotic process. At 10°C hypothermia, the ultrastructural findings indicate that the 
sensory cortex was in Phase I, showing only dilation of the rough endoplasmic reticulum 
and detachment of ribosomes.  Although both groups appear to be in earlier stages of 
apoptosis, the findings clearly indicate that HCA at 18°C is associated with more 
morphological characteristics of apoptosis, compared to 10°C. 
Although subtle, electron microscopy showed that at 18°C cells exhibited dilation of the 
rough endoplasmic reticulum and mitochondria, ribosome detachment and Golgi derived 
vacuolation, while at 10°C cells exhibited only slight changes.  Our findings of significantly 
reduced TUNEL(+) staining, a concomitant increase in Bcl-2 expression and slightly 
decreased ultrastructural evidence of activation of programmed cell death support that deep 
hypothermia at 10°C further protects the sensory neocortex.  
9. Conclusions 
Cardiac surgeons are faced with the challenge of protecting the brain during the sensitive 
time of interruption of normal cerebral blood flow.  The brain is an exceptionally complex 
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organ with a functional anatomy that is difficult both to understand and assess.  
Experimental and clinical studies have shown that the mechanism of neural injury is 
multifactorial. As such, discussions regarding the best surgical strategies for 
neuroprotection during circulatory arrest are formidable, at best. Although we are armed 
with excellent experimental and clinical studies that demonstrate the deleterious effects of 
prolonged exposure to cardiopulmonary bypass (CPB) on brain function and structure, the 
various neuroprotective strategies, particularly that of deep hypothermic circulatory arrest 
(DHCA) remain an issue of debate. This is related in part to the gap between the basic 
science understanding of brain injury caused by these events and the clinical application of 
various neuroprotective strategies and their subsequent clinical outcomes.  
Our goal has been to assess a possible mechanism of the neuronal injury (eg apoptosis) 
following DHCA. As this appears to involve a subtle and complex cascade of events, we 
decided to apply a paradigm that on the one hand may not be totally clinically relevant, but 
on the other hand would allow a robust response for assessment. Further study is clearly 
warranted to unravel relevant mechanisms and sensitive markers, which in turn, would 
allow us to appreciate the potential clinical relevance of these experimental findings. 
Evaluating various strategies and treatments in animal studies in order to determine clinical 
feasibility remains a challenge. Animal models have contributed immensely to our 
understanding of cerebral consequences of HCA, with several animal models having been 
used. To date, the preclinical investigation of cerebral injury mechanisms related to deep 
hypothermic circulatory arrest has been limited to large-animal models (porcine, canine and 
ovine). These models are expensive, personnel demanding, cumbersome and are usually 
performed without validated neuropsychologic assessment. Rodent models have been 
attempted to overcome some of these disadvantages, although treatment effects cannot 
always be confirmed in the rat model. Ultimately, however, each experimental model 
system from cell cultures to rats, to large animals and ultimately to clinical trials, have their 
advantages and disadvantages, and ultimately their place in these investigations.  
There is now convincing evidence that there is a general relationship between CNS damage 
and increasing duration of DHCA.  Although one of the goals of experimental studies is to 
assess the upper safe limit of DHCA, in order to do so we must more clearly understand the 
mechanism of cerebral injury. In most animal models, an extended period of arrest is 
necessary to produce a consistent and reproducible level of neuronal injury that would 
facilitate elucidating the mechanisms of injury, as well as the efficacy of potential 
neuroprotective interventions. Many large animal models require DHCA for at least 90-120 
minutes in order to demonstrate neurologic deficits. Although such prolonged DHCA 
interval might not be considered clinically realistic, they may be more appropriate for 
demonstrating the molecular pathways behind acute neuronal injury and hence, modes of 
intervention. 
Profound hypothermia of the brain results in a reduction of cerebral blood flow and steady 
state cerebral oxygen consumption (considered a true index of brain metabolic activity). 
Research in laboratory animals and clinical observations have now documented that 
considerable residual cerebral metabolism remains with cooling to levels of 15-18oC, 
particularly when cooling interval are short. Both experimental and clinical paradigms are 
faced with unresolved issues, including cooling gradients, nonuniformity of brain cooling, 
rewarming, pH management, among others. 
Various strategies have been addressed in an effort to reduce neurological complications, 
including profound hypothermia, antegrade cerebral perfusion, retrograde cerebral 
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perfusion, etc, each with their advantages and disadvantages. Cold reperfusion has shown 
promising results in animal studies and needs further clinical evaluation, while 
pharmacological interventions may offer a very promising pathway for preventing cerebral 
injury. 
Experimental study of a neuroprotective strategy includes appropriate selection of an 
animal model, as well as functional indices.  Of the available animal models, selection is 
made with respect to their relevance and feasibility of assessing the parameters of interest.  
The later are identified in the context of the available data.    Investigations of promising 
neuroprotectvie methods require validation in an experimental model (validation study), 
use of the method in experimental settings to optimize cerebral protection during CPB and 
DHCA (performance study) and test its utility during routine cardiac surgery (clinical 
study).  Despite the plethora of experimental and clinical studies, we still require a clearer 
understanding of the pathophysiologic consequences of HCA.  This information will be 
pivotal in clinical decision-making, including when to initiate circulatory arrest and the 
appropriate interval.  
Delayed cell death via apoptotic pathways is of special interest because of the potential for 
intervention. Although apoptosis is believed to play a part in the cerebral injury, its role has 
generally been identified through histologic techniques in animal models.  These snapshots 
do not permit a clear delineation of the time-line of apoptosis in the course of HCA.  Because 
it clinical role is not clear, therapies have yet to be designed for the specific purpose of 
inhibiting apoptosis.  Both the cascade of events and identification of pharmacologic agents 
that can act on molecular mediators require active investigation. 
Rewarming represents a critical time period, during which any additional harm to cerebral 
cells might induce permanent injury or even precipitate their death. How rapidly a stable 
energetic and biochemical homeostasis can be obtained in order to prevent the occurrence of 
secondary injuries remains unclear. 
Optimal perfusion characteristics required to reduce neurologic morbidity remain important 
issues for experimental study.  While there is ample evidence supporting the effectiveness of 
antegrade perfusion, its optimal delivery and perfusion characteristics remain unclear. 
Overall, there are still many gaps in our knowledge about how to best study cerebral 
outcome following DHCA.  The wealth of available evidence suggests that investigations 
require coordinated efforts by multiple research groups, pursuing systematic, multilevel 
research – spanning from cell cultures, to various animal model systems ranging from 
rodents to large animals and ultimately to clinical trials.  
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